Related references
Note: Only part of the references are listed.Dramatic reduction of sequence artefacts from DNA isolated from formalin-fixed cancer biopsies by treatment with uracil-DNA glycosylase.
Hongdo Do et al.
Oncotarget (2015)
Comparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutations
Michaela Angelika Ihle et al.
BMC CANCER (2014)
Performance of Common Analysis Methods for Detecting Low-Frequency Single Nucleotide Variants in Targeted Next-Generation Sequence Data
David H. Spencer et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2014)
Liquid biopsy in gastrointestinal stromal tumors: a novel approach
Margherita Nannini et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Clonal evolution in hematological malignancies and therapeutic implications
D. A. Landau et al.
LEUKEMIA (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Adapting Clinical Paradigms to the Challenges of Cancer Clonal Evolution
Nirupa Murugaesu et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Gastrointestinal Stromal Tumors With KIT Exon 9 Mutations
Helen Künstlinger et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
Cellular Heterogeneity and Molecular Evolution in Cancer
Vanessa Almendro et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 8 (2013)
Accurate single nucleotide variant detection in viral populations by combining probabilistic clustering with a statistical test of strand bias
Kerensa McElroy et al.
BMC GENOMICS (2013)
Detection of Mutant Free Circulating Tumor DNA in the Plasma of Patients with Gastrointestinal Stromal Tumor Harboring Activating Mutations of CKIT or PDGFRA
Jacqueline Maier et al.
CLINICAL CANCER RESEARCH (2013)
Reducing Sequence Artifacts in Amplicon-Based Massively Parallel Sequencing of Formalin-Fixed Paraffin-Embedded DNA by Enzymatic Depletion of Uracil-Containing Templates
Hongdo Do et al.
CLINICAL CHEMISTRY (2013)
Comparison of Clinical Targeted Next-Generation Sequence Data from Formalin-Fixed and Fresh-Frozen Tissue Specimens
David H. Spencer et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2013)
Targeted, High-Depth, Next-Generation Sequencing of Cancer Genes in Formalin-Fixed, Paraffin-Embedded and Fine-Needle Aspiration Tumor Specimens
Andrew G. Hadd et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2013)
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
Garrett M. Frampton et al.
NATURE BIOTECHNOLOGY (2013)
Mechanisms and insights into drug resistance in cancer
Hiba Zahreddine et al.
FRONTIERS IN PHARMACOLOGY (2013)
Breast cancer intratumor genetic heterogeneity: causes and implications
Charlotte K. Y. Ng et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2012)
Mechanisms of acquired resistance to targeted cancer therapies
Mark R. Lackner et al.
FUTURE ONCOLOGY (2012)
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
Martin Peifer et al.
NATURE GENETICS (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Ultrasensitive detection of rare mutations using next-generation targeted resequencing
Patrick Flaherty et al.
NUCLEIC ACIDS RESEARCH (2012)
p53 Modulation as a Therapeutic Strategy in Gastrointestinal Stromal Tumors
Joern Henze et al.
PLOS ONE (2012)
Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA
Tim Forshew et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Reliable detection of subclonal single-nucleotide variants in tumour cell populations
Moritz Gerstung et al.
NATURE COMMUNICATIONS (2012)
Identification of errors introduced during high throughput sequencing of the T cell receptor repertoire
Phuong Nguyen et al.
BMC GENOMICS (2011)
Targeted high throughput sequencing in clinical cancer Settings: formaldehyde fixed-paraffin embedded (FFPE) tumor tissues, input amount and tumor heterogeneity
Martin Kerick et al.
BMC MEDICAL GENOMICS (2011)
Pretreatment EGFR T790M Mutation and BRCA1 mRNA Expression in Erlotinib-Treated Advanced Non-Small-Cell Lung Cancer Patients with EGFR Mutations
Rafael Rosell et al.
CLINICAL CANCER RESEARCH (2011)
The GIST paradigm: lessons for other kinase-driven cancers
Cristina R. Antonescu
JOURNAL OF PATHOLOGY (2011)
Large Scale Loss of Data in Low-Diversity Illumina Sequencing Libraries Can Be Recovered by Deferred Cluster Calling
Felix Krueger et al.
PLOS ONE (2011)
Detection and quantification of rare mutations with massively parallel sequencing
Isaac Kinde et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Pitfall in mutational testing and reporting of common KIT and PDGFRA mutations in gastrointestinal stromal tumors
Sabine Merkelbach-Bruse et al.
BMC MEDICAL GENETICS (2010)
Resistance to Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors
Ann W. Gramza et al.
CLINICAL CANCER RESEARCH (2009)
Limited copy number-high resolution melting (LCN-HRM) enables the detection and identification by sequencing of low level mutations in cancer biopsies
Hongdo Do et al.
MOLECULAR CANCER (2009)
Heterogeneity of kinase inhibitor resistance mechanisms in GIST
B. Liegl et al.
JOURNAL OF PATHOLOGY (2008)
Polyclonal evolution of multiple secondary KIT mutations in gastrointestinal stromal tumors under treatment with imatinib mesylate
E Wardelmann et al.
CLINICAL CANCER RESEARCH (2006)
Acquired resistance to imatinib in gastrointestinal stromal tumours caused by multiple KIT mutations
E Wardelmann et al.
LANCET ONCOLOGY (2005)
Low copy number DNA template can render polymerase chain reaction error prone in a sequence-dependent manner
M Akbari et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2005)
Effect of fixatives and tissue processing on the content and integrity of nucleic acids
M Srinivasan et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Share Paper
